BATS BZX Real-Time Price
As of 2:41pm ET
| +0.14 / +0.73%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a +44.40% increase from the last price of 19.39.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.